- Home
- TEVA vs PNR Comparison
TEVA vs PNR Comparison
Compare TEVA & PNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- PNR
- Stock Information
- Founded
- TEVA 1901
- PNR 1966
- Country
- TEVA Israel
- PNR United Kingdom
- Employees
- TEVA N/A
- PNR N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- PNR Industrial Machinery/Components
- Sector
- TEVA Health Care
- PNR Industrials
- Exchange
- TEVA Nasdaq
- PNR Nasdaq
- Market Cap
- TEVA 19.2B
- PNR 16.3B
- IPO Year
- TEVA N/A
- PNR N/A
- Fundamental
- Price
- TEVA $17.16
- PNR $106.29
- Analyst Decision
- TEVA Strong Buy
- PNR Buy
- Analyst Count
- TEVA 8
- PNR 15
- Target Price
- TEVA $19.63
- PNR $105.50
- AVG Volume (30 Days)
- TEVA 7.4M
- PNR 1.4M
- Earning Date
- TEVA 11-06-2024
- PNR 10-22-2024
- Dividend Yield
- TEVA N/A
- PNR 0.88%
- EPS Growth
- TEVA N/A
- PNR 29.67
- EPS
- TEVA N/A
- PNR 4.00
- Revenue
- TEVA $16,772,000,000.00
- PNR $4,094,500,000.00
- Revenue This Year
- TEVA $4.70
- PNR $0.48
- Revenue Next Year
- TEVA $4.47
- PNR $4.15
- P/E Ratio
- TEVA N/A
- PNR $26.09
- Revenue Growth
- TEVA 9.81
- PNR N/A
- 52 Week Low
- TEVA $9.35
- PNR $62.33
- 52 Week High
- TEVA $19.31
- PNR $107.78
- Technical
- Relative Strength Index (RSI)
- TEVA 44.51
- PNR 65.89
- Support Level
- TEVA $16.15
- PNR $103.57
- Resistance Level
- TEVA $17.16
- PNR $107.78
- Average True Range (ATR)
- TEVA 0.49
- PNR 2.24
- MACD
- TEVA -0.07
- PNR -0.07
- Stochastic Oscillator
- TEVA 30.38
- PNR 74.64
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About PNR Pentair plc.
Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Pentair's business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.1 billion in revenue in 2023.